In order to relieve anxiety and depression accompanying stress, physicians resort to tricyclic antidepressants, such as imipramine. We had previously shown that imipramine reversed stress-induced social avoidance behavior, and down-regulated microglial activation 24 days after stress cessation. To further characterize the effects of imipramine on stress induced neuroimmune dysregulation and associated changes in behavior, the aims of this study were to determine if imipramine 1) ameliorated stressinduced inflammation in the periphery and central nervous system, and 2) prevented stress related anxiety-and depressive-like behaviors. C57BL/6 mice were treated with imipramine (15 mg/kg) in their drinking water, and exposed to repeated social defeat (RSD). Imipramine attenuated stress-induced corticosterone and IL-6 responses in plasma. Imipramine decreased the percentage of monocytes and granulocytes in the bone marrow and circulation. However, imipramine did not prevent splenomegaly, stress-related increased percentage of granulocytes in this organ, and the production of proinflammatory cytokines in the spleen, following RSD. Moreover, imipramine abrogated the accumulation of macrophages in the brain in mice exposed to RSD. Imipramine blocked neuroinflammatory signaling and prevented stress-related anxiety-and depressive-like behaviors. These data support the notion that pharmacomodulation of the monoaminergic system, besides exerting anxiolytic and antidepressant effects, may have therapeutic effects as a neuroimmunomodulator during stress.
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Introduction
The prolonged inflammatory state associated with social stress has the potential to contribute to the etiology of anxiety and depression. Analysis of peripheral inflammatory markers in patients with mood disorders reveals constant elevations in interleukin-6 (IL-6), interleukin-1b (IL-1b), and tumor necrosis factor-a (TNF-a) (Russo and Nestler, 2013) . There is evidence that activation of microglia in animal models of stress, potentiates hypothalamic-pituitary-adrenal (HPA) axis stimulation through the release of IL-1b within the hypothalamus (Goshen and Yirmiya, 2009), augmenting neuroendocrine outflow that may reinforce stress-associated behaviors. Thus, physiological microglia alterations are likely to contribute to the dysfunctional neurobiological stress interpretation in the CNS.
Repeated social defeat (RSD), a model of psychosocial stress in mice, provides a probe to study the mechanisms leading to stress-related alterations in inflammation in both the periphery and CNS, and associated anxiety-and depressive-like behaviors (Kinsey et al., 2007; Wohleb et al., 2013) . RSD causes an increase in pro-inflammatory factors and enhances the capacity of immune cells to enter circulation and organs, such as the spleen and brain. Also, RSD augments levels of corticosterone in circulation following the second cycle of RSD, and peaks at the sixth cycle (Engler et al., 2005 
